U.S. Food and Drug Administration (FDA) · United States

FDA Off-Label Promotion - Prohibited Practices and Safe Harbors

Prescription drug promotion must stay within the approved indication; information on unapproved uses may be shared only separately from promotion under FDA's safe-harbor guidance or in reply to unsolicited requests.

21 U.S.C. 331(a), 352(a)(1), 352(f); 21 CFR 201.128; 21 CFR 202.1(e)(6)(i), (xi)

What is FDA Off-Label Promotion - Prohibited Practices and Safe Harbors?

Prescription drug promotion must stay within the approved indication; information on unapproved uses may be shared only separately from promotion under FDA's safe-harbor guidance or in reply to unsolicited requests. Apply to US prescription drug ads, sales aids, emails and websites for promotion of unapproved uses.

US Federal

Read official source

Last reviewed: 2026-11-05

General information, not legal advice.

Who does this rule apply to?

general_audience, general_adults_18plus, customers, health_professionals · Prescription Drug · pharma

Where does this rule apply?

United States

Which marketing channels are covered?

all_channels

When does this rule take effect?

2026-05-10

What does this rule require?

Prescription drug promotion must stay within the approved indication; information on unapproved uses may be shared only separately from promotion under FDA's safe-harbor guidance or in reply to unsolicited requests.

How can marketing teams comply?

Apply to US prescription drug ads, sales aids, emails and websites for promotion of unapproved uses.

Where can I read the official source?

Read official source

Key facts

Regulatory authority
U.S. Food and Drug Administration (FDA)
Jurisdiction
United States
Official citation
21 U.S.C. 331(a), 352(a)(1), 352(f); 21 CFR 201.128; 21 CFR 202.1(e)(6)(i), (xi)
Published
2026-11-16
Effective date
2026-05-10
Channel
all_channels
Products
Prescription Drug
Audiences
general_audience, general_adults_18plus, customers, health_professionals

Frequently asked questions

What is FDA Off-Label Promotion - Prohibited Practices and Safe Harbors?

Prescription drug promotion must stay within the approved indication; information on unapproved uses may be shared only separately from promotion under FDA's safe-harbor guidance or in reply to unsolicited requests.

Who does this rule apply to?

general_audience, general_adults_18plus, customers, health_professionals · Prescription Drug · pharma

Where does this rule apply?

United States

Which marketing channels are covered?

all_channels

When does this rule take effect?

2026-05-10

Request a free compliance scan of your homepage and book a time with Warrant.

Get a free homepage compliance scan